Tumor Biology

, Volume 37, Issue 7, pp 8791–8798 | Cite as

A novel variable exonic region and differential expression of LINC00663 non-coding RNA in various cancer cell lines and normal human tissue samples

  • Esra Bozgeyik
  • Yusuf Ziya Igci
  • Mevan F. Sami Jacksi
  • Kaifee Arman
  • Serdar A. Gurses
  • Ibrahim Bozgeyik
  • Elif Pala
  • Onder Yumrutas
  • Ebru Temiz
  • Mehri Igci
Original Article


Long non-coding RNAs (lncRNAs) are found to play crucial roles in several biological processes and have been associated with many complex human diseases including cancers. Several lines of evidences indicate that lncRNAs deregulated in many cancer tissues. In this particular study, differential expression of long intergenic non-coding RNA 663 (LINC00663) was demonstrated in various cancer cell lines and healthy human tissues by using RT-PCR and qPCR methods. While expression level of LINC00663 was most prominent in thyroid gland and uterus, it is least expressed in skeletal muscle tissues. Moreover, LINC00663 was found to be differentially expressed in various cancer cells. Particularly, its expression was highly diminished in DU-145, PC3, HGC-27, CRL-1469, A549, MCF7, and BCPAP cancer cells. Also, LINC00663 expression was most prominent in A172 glioblastoma cells. Additionally, a novel splice variant of LINC00663 RNA was also detected. The sequence and Basic Local Alignment Search Tool (BLAST) analysis results revealed the presence of a novel exonic region between exons 2 and 3. Subsequently, five potential splice variants showing high level of variation have been identified. Secondary structures of these variants with minimum free energy were also demonstrated. Furthermore, putative microRNA (miRNA) binding sites to these variants have been shown. In conclusion, LINC00663 was shown to be differentially expressed in various human tissues and cancer cell lines. Also, LINC00663 undergoes alternative splicing and the novel exonic region alters its secondary structure and its interactions with potential targeting miRNAs. The role of LINC00663 in cancer formation further needs to be investigated with a wide range of studies.


Cancer Non-coding RNA LINC00663 lncRNA miRNA 



Kaifee Arman is a recipient of Graduate Scholarship from Turkish Scientific and Technological Research Council (TUBITAK) under the program 2215-Graduate Scholarship Programme for International Students.

Compliance with ethical standards

Conflicts of interest



  1. 1.
    Esteller M. Non-coding RNAs in human disease. Nat Rev Genet. 2011;12:861–74.CrossRefPubMedGoogle Scholar
  2. 2.
    Gutschner T, Diederichs S. The hallmarks of cancer. RNA Biol. 2012;9:703–19.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Fatica A, Bozzoni I. Long non-coding RNAs: new players in cell differentiation and development. Nat Rev Genet. 2014;15:7–21.CrossRefPubMedGoogle Scholar
  4. 4.
    Mercer TR, Dinger ME, Mattick JS. Long non-coding RNAs: insights into functions. Nat Rev Genet. 2009;10:155–9.CrossRefPubMedGoogle Scholar
  5. 5.
    Morris KV, Mattick JS. The rise of regulatory RNA. Nat Rev Genet. 2014;15:423–37.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Kara M, Yumrutas O, Ozcan O, Celik OI, Bozgeyik E, Bozgeyik I, et al. Differential expressions of cancer-associated genes and their regulatory miRNAs in colorectal carcinoma. Gene. 2015.Google Scholar
  7. 7.
    Ohtsuka M, Ling H, Doki Y, Mori M, Calin GA. MicroRNA processing and human cancer. J Clin Med. 2015;4:1651–67.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Neguembor MV, Jothi M, Gabellini D. Long noncoding RNAs, emerging players in muscle differentiation and disease. Skelet Muscle. 2014;4:8.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Shi X, Sun M, Liu H, Yao Y, Song Y. Long non-coding RNAs: a new frontier in the study of human diseases. Cancer Lett. 2013;339:159–66.CrossRefPubMedGoogle Scholar
  10. 10.
    Zhou X, Liu S, Cai G, Kong L, Zhang T, Ren Y, et al. Long non coding RNA MALAT1 promotes tumor growth and metastasis by inducing epithelial-mesenchymal transition in oral squamous cell carcinoma. Sci Rep. 2015;5.Google Scholar
  11. 11.
    Bhan A, Mandal SS. LncRNA HOTAIR: a master regulator of chromatin dynamics and cancer. Biochimica et Biophysica Acta (BBA)-Rev Cancer. 2015;1856:151–64.CrossRefGoogle Scholar
  12. 12.
    Wright MW. A short guide to long non-coding RNA gene nomenclature. Human Genomics. 2014;8:7.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Igci YZ, Arslan A, Akarsu E, Erkilic S, Igci M, Oztuzcu S, et al. Differential expression of a set of genes in follicular and classic variants of papillary thyroid carcinoma. Endocr Pathol. 2011;22:86–96.CrossRefPubMedGoogle Scholar
  14. 14.
    Gruber AR, Lorenz R, Bernhart SH, Neubock R, Hofacker IL. The Vienna RNA websuite. Nucleic Acids Res. 2008;36:W70–4.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Kozomara A, Griffiths-Jones S. Mirbase: Integrating microRNA annotation and deep-sequencing data. Nucleic acids research 2010:gkq1027.Google Scholar
  16. 16.
    Kozomara A, Griffiths-Jones S. Mirbase: annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res 2015:gkt1181.Google Scholar
  17. 17.
    Azzalin CM, Reichenbach P, Khoriauli L, Giulotto E, Lingner J. Telomeric repeat-containing RNA and RNA surveillance factors at mammalian chromosome ends. Science. 2007;318:798–801.CrossRefPubMedGoogle Scholar
  18. 18.
    de Kok JB, Verhaegh GW, Roelofs RW, Hessels D, Kiemeney LA, Aalders TW, et al. Dd3pca3, a very sensitive and specific marker to detect prostate tumors. Cancer Res. 2002;62:2695–8.PubMedGoogle Scholar
  19. 19.
    Hessels D, Klein Gunnewiek JMT, van Oort I, Karthaus HFM, van Leenders GJL, van Balken B, et al. Dd3 pca3-based molecular urine analysis for the diagnosis of prostate cancer. Eur Urol. 2003;44:8–16.CrossRefPubMedGoogle Scholar
  20. 20.
    Tsang FHC, Au SLK, Wei L, Fan DNY, Lee JMF, Wong CCL, et al. Long non-coding RNA HOTTIP is frequently up-regulated in hepatocellular carcinoma and is targeted by tumour suppressive mir-125b. Liver Int. 2015;35:1597–606.CrossRefPubMedGoogle Scholar
  21. 21.
    Xu G, Chen J, Pan Q, Huang K, Pan J, Zhang W, et al. Long noncoding RNA expression profiles of lung adenocarcinoma ascertained by microarray analysis. PLoS One. 2014;9, e104044.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Bovolenta M, Erriquez D, Valli E, Brioschi S, Scotton C, Neri M, et al. The DMD locus harbours multiple long non-coding RNAs which orchestrate and control transcription of muscle dystrophin mRNA isoforms. PLoS One. 2012;7, e45328.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Pan Q, Shai O, Lee LJ, Frey BJ, Blencowe BJ. Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat Genet. 2008;40:1413–5.CrossRefPubMedGoogle Scholar
  24. 24.
    Modrek B, Lee C. A genomic view of alternative splicing. Nat Genet. 2002;30:13–9.CrossRefPubMedGoogle Scholar
  25. 25.
    Li J-H, Liu S, Zhou H, Qu L-H, Yang J-H. Starbase v2. 0: Decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale clip-seq data. Nucleic acids research 2013:gkt1248.Google Scholar
  26. 26.
    Wu T, Wang J, Liu C, Zhang Y, Shi B, Zhu X, et al. Npinter: the noncoding RNAs and protein related biomacromolecules interaction database. Nucleic Acids Res. 2006;34:D150–2.CrossRefPubMedGoogle Scholar
  27. 27.
    Xie C, Yuan J, Li H, Li M, Zhao G, Bu D, et al. Noncodev4: exploring the world of long non-coding RNA genes. Nucleic Acids Res. 2013;42:D98–D103.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2016

Authors and Affiliations

  • Esra Bozgeyik
    • 1
  • Yusuf Ziya Igci
    • 1
  • Mevan F. Sami Jacksi
    • 1
  • Kaifee Arman
    • 1
  • Serdar A. Gurses
    • 2
  • Ibrahim Bozgeyik
    • 3
  • Elif Pala
    • 4
  • Onder Yumrutas
    • 3
  • Ebru Temiz
    • 1
  • Mehri Igci
    • 1
  1. 1.Faculty of Medicine, Department of Medical BiologyUniversity of GaziantepGaziantepTurkey
  2. 2.Faculty of Medicine, Department of Medical BiologyZirve UniversityGaziantepTurkey
  3. 3.Department of Medical BiologyAdiyaman UniversityAdiyamanTurkey
  4. 4.Department of Medical BiologySanko UniversityGaziantepTurkey

Personalised recommendations